siRNA Against KIR3DL1 as a Potential Gene Therapeutic Agent in Controlling HIV-1 Infection-Reference-Cited by-同舟云学术

siRNA Against KIR3DL1 as a Potential Gene Therapeutic Agent in Controlling HIV-1 Infection

Published:2014-06 Issue:5 Volume:27 Page:207-213
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Fu Geng-Feng¹,Pan Ji-Cheng²,Lin Nan³,Hu Hai-Yang¹,Tang Wei-Ming⁴,Xu Jin-Shui¹,Wang Xiao-Liang¹,Xu Xiao-Qin¹,Qiu Tao¹,Liu Xiao-Yan¹,Chen Guo-Hong¹,Mahapatra Tanmay⁴,Huan Xi-Ping¹,Yang Hai-Tao¹

Affiliation:

1. Jiangsu Provincial Center for Disease Prevention and Control, Nanjing, China.

2. Jiangsu Province Geriatric Institute, Nanjing, China.

3. College of Ocean and Earth Science, Xiamen University, Xiamen, China.

4. Department of Epidemiology, School of Public Health, University of California, Los Angeles, California.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2013.0126

Reference28 articles.

1. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

2. HIV-1 Escape From RNAi Antivirals: Yet Another Houdini Action?

3. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection

4. HIV Protective KIR3DL1 and HLA-B Genotypes Influence NK Cell Function Following Stimulation with HLA-Devoid Cells

5. The promises and pitfalls of RNA-interference-based therapeutics

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways;Mitochondrion;2024-09

2. Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery;BioImpacts;2017-08-23

3. Potential application of injectable chitosan hydrogel treated with siRNA in chronic rhinosinusitis therapy;Molecular Medicine Reports;2015-08-21